Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001995218-26-000002

Chief Executive Officer acquired 161,665 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Townsend Richard Nolan Chief Executive Officer 2026-02-04 Grant or award +161,665 402,656 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Townsend Richard Nolan Chief Executive Officer 2026-02-04 Grant or award · Stock Option (right to buy) +646,665 646,665 D: show line 2 in the form
Loading xslF345X05/form4-02062026_050205.xml…